SCHEMBL650579

SCHEMBL650579

CC(C)O/C=C(\Br)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1544551 1.00
SCHEMBL648003 1.00
SCHEMBL16327975 0.76
SCHEMBL13848749 0.72
SCHEMBL11163142 0.70
SCHEMBL8626148 0.70
SCHEMBL12704754 0.70
SCHEMBL11495563 0.70
SCHEMBL14297400 0.70
SCHEMBL13792239 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899328-B1 A PROCESS FOR THE PREPARATION OF LOSARTAN DERIVATIVES BY CHLORINATION AND REDUCTION OF THE RESPECTIVE 1H-IMIDAZOLE-5-CARBALDEHYDES KRKA D D NOVO MESTO (SI) 2009-03-04 EP claimed
EP-1899328-A1 A PROCESS FOR THE PREPARATION OF LOSARTAN DERIVATIVES BY CHLORINATION AND REDUCTION OF THE RESPECTIVE 1H-IMIDAZOLE-5-CARBALDEHYDES KRKA, D.D., Novo Mesto (SI) 2008-03-19 EP claimed
WO-2007003280-A1 A PROCESS FOR THE PREPARATION OF LOSARTAN DERIVATIVES BY CHLORINATION AND REDUCTION OF THE RESPECTIVE 1H-IMIDAZOLE-5-CARBALDEHYDES KRKA, D.D. NOVO MESTO (SI) 2007-01-11 WO claimed
EP-1741711-A1 A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1H-imidazole-5-carbaldehydes KRKA, D.D., Novo Mesto (SI) 2007-01-10 EP claimed
US-12528781-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2026-01-20 US disclosed
EP-4192831-B1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO INC (US) 2025-10-22 EP disclosed
US-20240376061-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2024-11-14 US disclosed
US-11897851-B2 Heterocyclic GLP-1 agonists GASHERBRUM BIO, INC. (US) 2024-02-13 US disclosed
CN-116323599-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2023-06-23 CN disclosed
US-20230192633-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-06-22 US disclosed
US-20230192633-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-06-22 US disclosed
US-20230192633-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-06-22 US disclosed
EP-0850225-A1 INTERMEDIATE FOR PREPARING A PHARMACEUTICALLY ACTIVE COMPOUND SMITHKLINE BEECHAM CORPORATION (US) 1998-07-01 EP disclosed
EP-0850225-A4 1998-07-01 EP disclosed
US-5719293-A Intermediate for preparing a pharmaceutically active compound SMITHKLINE BEECHAM CORPORATION (US) 1998-02-17 US disclosed
US-5565577-A Process for preparing 1-alkyaryl-2-alkyl-5-formylimidazole SMITHKLINE BEECHAM CORPORATION (US) 1996-10-15 US disclosed
EP-0662961-A4 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS. SMITHKLINE BEECHAM CORP (US) 1996-07-31 EP disclosed
WO-1995032189-A1 INTERMEDIATE FOR PREPARING A PHARMACEUTICALLY ACTIVE COMPOUND SMITHKLINE BEECHAM CORPORATION (US) 1995-11-30 WO disclosed
EP-0662961-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1995-07-19 EP disclosed
WO-1994006776-A1 PROCESS OF SYNTHESIZING USEFUL INTERMEDIATES OF SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-03-31 WO disclosed